King Charles shared his cancer diagnosis in February 2024 after undergoing a procedure for an enlarged prostate and has received treatment that will be 'reduced' in 2026. Here's everything to know ...
Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC ...
GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.
Gilead Sciences and Arcus Biosciences said on Friday they would stop a late-stage study testing their experimental cancer ...
Shares in biopharmaceutical company Arcus Biosciences ($RCUS) collapsed 17% in pre-market trading after it said it was ...
Colon cancer is increasingly affecting young adults. A gastroenterologist explained what a healthy colon looks like and the changes that occur when abnormal cells begin to grow, causing cancer. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback